anaplastic large cell lymphoma
The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
The <span class="gene" id="17157164-0-4-9">HSP90</span> inhibitor 17-AAG synergizes with doxorubicin and U0126 in <span class="disease" id="17157164-0-68-98">anaplastic large cell lymphoma</span> irrespective of ALK expression.